Company intelligence
CheckRare
Leading Publisher and Learning Platform Focused on Rare Diseases.
About CheckRare
CheckRare is a learning platform for health care professionals and patients. Our platform allows users to gain insight and learn about rare diseases, current and emerging therapies, clinical trials, and the BioPharma companies behind them. Our peer-to-peer content is a trusted source for education and industry-related content. Our native content and sponsored programs are developed through our website, e-newsletter, social media platforms, and live meetings. We are a trusted, strategic partner with all major organizations in the global network of rare disease advisors and advocates.
Verified activity
Signals from CheckRare
3 published signals
Presence & Recognition
CheckRare launched a new CME program available at the American Academy of Neurology Annual Meeting 2026 for clinical research highlights in myasthenia gravis.
Reported by CheckRare
Presence & Recognition
CheckRare announced the creation of a new learning center for Congenital Adrenal Hyperplasia.
Reported by CheckRare
Presence & Recognition
CheckRare is participating in Narcolepsy Awareness Month by sharing stories and raising awareness about narcolepsy.
Reported by CheckRare